Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer

NCT00223158 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer

Interventions

DRUG: Liothyronine

Sponsor

Patrice Perron

Collaborators

[object Object]